{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:26:57Z","timestamp":1762957617731,"version":"3.44.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41569-025-01138-x","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T08:49:16Z","timestamp":1740559756000},"page":"564-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endomyocardial fibrosis: recent advances and future therapeutic targets"],"prefix":"10.1038","volume":"22","author":[{"given":"Ana O.","family":"Mocumbi","sequence":"first","affiliation":[]},{"given":"Viviane Tiemi","family":"Hotta","sequence":"additional","affiliation":[]},{"given":"Gene","family":"Bukhman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-7883","authenticated-orcid":false,"given":"Ntobeko","family":"Ntusi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-8245","authenticated-orcid":false,"given":"Magdi H.","family":"Yacoub","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6114-9189","authenticated-orcid":false,"given":"Paulo","family":"Correia-de-S\u00e1","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"1138_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11886-019-1244-3","volume":"21","author":"AO Mocumbi","year":"2019","unstructured":"Mocumbi, A. O., Stothard, J. R., Correia-de-S\u00e1, P. & Yacoub, M.\u00a0Endomyocardial fibrosis: an update after 70 years. Curr. Cardiol. Rep. 21, 148 (2019).","journal-title":"Curr. Cardiol. Rep."},{"key":"1138_CR2","first-page":"729","volume":"136","author":"G Vijayaraghavan","year":"2012","unstructured":"Vijayaraghavan, G. & Sivasankaran, S. Tropical endomyocardial fibrosis in India: a vanishing disease! Indian. J. Med. Res. 136, 729\u2013738 (2012).","journal-title":"Indian. J. Med. Res."},{"key":"1138_CR3","doi-asserted-by":"publisher","first-page":"841346","DOI":"10.3389\/fcvm.2022.841346","volume":"9","author":"TO Aliku","year":"2022","unstructured":"Aliku, T. O. et al. Trends in annual incidence rates of newly diagnosed endomyocardial fibrosis cases at the Uganda Heart Institute: a 14-year review. Front. Cardiovasc. Med. 9, 841346 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1138_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10741-019-09848-4","volume":"25","author":"AR Duraes","year":"2020","unstructured":"Duraes, A. R., de Souza Lima Bitar, Y., Roever, L. & Neto, M. G. Endomyocardial fibrosis: past, present, and future. Heart Fail. Rev. 25, 725\u2013730 (2020).","journal-title":"Heart Fail. Rev."},{"key":"1138_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-3156.1999.43376.x","volume":"4","author":"M Rutakingirwa","year":"1999","unstructured":"Rutakingirwa, M., Ziegler, J. L., Newton, R. & Freers, J. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop. Med. Int. Health 4, 229\u2013235 (1999).","journal-title":"Trop. Med. Int. Health"},{"key":"1138_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000097","volume":"2","author":"G Bukhman","year":"2008","unstructured":"Bukhman, G., Ziegler, J. & Parry, E.\u00a0Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl. Trop. Dis. 2, e97 (2008).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1138_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/hrt.2008.148437","volume":"95","author":"S Sivasankaran","year":"2009","unstructured":"Sivasankaran, S. Restrictive cardiomyopathy in India: the story of a vanishing mystery. Heart 95, 9\u201314 (2009).","journal-title":"Heart"},{"key":"1138_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa0708629","volume":"359","author":"AO Mocumbi","year":"2008","unstructured":"Mocumbi, A. O., Ferreira, M. B., Sidi, D. & Yacoub, M. H.\u00a0A population study of endomyocardial fibrosis in a rural area of Mozambique. N. Engl. J. Med. 359, 43\u201349 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1138_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/pgmj.59.689.179","volume":"59","author":"J Davies","year":"1983","unstructured":"Davies, J., Spry, C. J., Vijayaraghavan, G. & De Souza, J. A. A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad. Med. J. 59, 179\u2013185 (1983).","journal-title":"Postgrad. Med. J."},{"key":"1138_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ihj.2016.12.015","volume":"70","author":"PN Gupta","year":"2018","unstructured":"Gupta, P. N. et al. Geographical variation in the clinical presentation of endomyocardial fibrosis in India? Indian. Heart J. 70, 56\u201365 (2018).","journal-title":"Indian. Heart J."},{"key":"1138_CR11","doi-asserted-by":"publisher","first-page":"100784","DOI":"10.1016\/j.cpcardiol.2020.100784","volume":"46","author":"CE Scatularo","year":"2021","unstructured":"Scatularo, C. E. et al. Endomyocardiofibrosis: a systematic review. Curr. Probl. Cardiol. 46, 100784 (2021).","journal-title":"Curr. Probl. Cardiol."},{"key":"1138_CR12","first-page":"49","volume":"49","author":"KT Kumari","year":"1997","unstructured":"Kumari, K. T., Ravikumar, A. & Kurup, P. A. \u00a0Accumulation of glycosaminoglycans associated with hypomagnesaemia in endomyocardial fibrosis in Kerala: possible involvement of dietary factors. Indian. Heart J. 49, 49\u201351 (1997).","journal-title":"Indian. Heart J."},{"key":"1138_CR13","first-page":"473","volume":"2014","author":"A Beaton","year":"2014","unstructured":"Beaton, A. et al. Genetic susceptibility to endomyocardial fibrosis. Glob. Cardiol. Sci. Pract. 2014, 473\u2013481 (2014).","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"1138_CR14","first-page":"175","volume":"18","author":"BM Mayosi","year":"2007","unstructured":"Mayosi, B. M. & Somers, K. Cardiomyopathy in Africa: heredity versus environment. Cardiovasc. J. Afr. 18, 175\u2013179 (2007).","journal-title":"Cardiovasc. J. Afr."},{"key":"1138_CR15","unstructured":"Bhatti, K., Bandlamudi M. & Lopez-Mattei, J. Endomyocardial fibrosis (StatPearls, 2025)."},{"key":"1138_CR16","first-page":"199","volume":"20","author":"JJ Andy","year":"2001","unstructured":"Andy, J. J. Aetiology of endomyocardial fibrosis (EMF). West. Afr. J. Med. 20, 199\u2013207 (2001).","journal-title":"West. Afr. J. Med."},{"key":"1138_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.4269\/ajtmh.14-0156","volume":"91","author":"AL Bustinduy","year":"2014","unstructured":"Bustinduy, A. L. et al. Endomyocardial fibrosis (EMF) in a Ugandan child with advanced hepatosplenic schistosomiasis: coincidence or connection? Am. J. Trop. Med. Hyg. 91, 798\u2013800 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1138_CR18","doi-asserted-by":"publisher","first-page":"ytac312","DOI":"10.1093\/ehjcr\/ytac312","volume":"6","author":"C Espinoza Romero","year":"2022","unstructured":"Espinoza Romero, C. et al. Endomyocardial fibrosis of the right ventricle in a patient with schistosomiasis: a case report. Eur. Heart J. Case Rep. 6, ytac312 (2022).","journal-title":"Eur. Heart J. Case Rep."},{"key":"1138_CR19","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.5830\/CVJA-2016-030","volume":"27","author":"AO Mocumbi","year":"2016","unstructured":"Mocumbi, A. O., Goncalves, C., Damasceno, A. & Carrilho, C.\u00a0Active schistosomiasis, severe hypereosinophilia and rapid progression of chronic endomyocardial fibrosis. Cardiovasc. J. Afr. 27, e4\u2013e6 (2016).","journal-title":"Cardiovasc. J. Afr."},{"key":"1138_CR20","first-page":"218","volume":"7","author":"WM Eling","year":"1983","unstructured":"Eling, W. M. et al. Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib. Microbiol. Immunol. 7, 218\u2013229 (1983).","journal-title":"Contrib. Microbiol. Immunol."},{"key":"1138_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/tropej\/fmp114","volume":"57","author":"AO Mocumbi","year":"2011","unstructured":"Mocumbi, A. O. et al. Lack of evidence of myocardial damage in children with Plasmodium falciparum severe and complicated malaria from an endemic area for endomyocardial fibrosis. J. Trop. Pediatr. 57, 312\u2013314 (2011).","journal-title":"J. Trop. Pediatr."},{"key":"1138_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF02785274","volume":"63","author":"CC Kartha","year":"1998","unstructured":"Kartha, C. C. et al. Pattern of cardiac fibrosis in rabbits periodically fed a magnesium-restricted diet and administered rare earth chloride through drinking water. Biol. Trace Elem. Res. 63, 19\u201330 (1998).","journal-title":"Biol. Trace Elem. Res."},{"key":"1138_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0022-2828(92)93391-V","volume":"24","author":"K Shivakumar","year":"1992","unstructured":"Shivakumar, K. et al. Paradoxical effect of cerium on collagen synthesis in cardiac fibroblasts. J. Mol. Cell. Cardiol. 24, 775\u2013780 (1992).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1138_CR24","first-page":"S24","volume":"73","author":"CL Sezi","year":"1996","unstructured":"Sezi, C. L. Effects of cassava diet on Cercopithecus aethiops livers: a case for cassava as the cause of both tropical splenomegaly syndrome (TSS) and endomyocardial fibrosis (EMF). East. Afr. Med. J. 73, S24\u2013S28 (1996).","journal-title":"East. Afr. Med. J."},{"key":"1138_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0167-5273(90)90265-7","volume":"29","author":"H Davies","year":"1990","unstructured":"Davies, H. Endomyocardial fibrosis and the tuberous diet. Int. J. Cardiol. 29, 3\u20138 (1990).","journal-title":"Int. J. Cardiol."},{"key":"1138_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007420","volume":"4","author":"M Wayengera","year":"2009","unstructured":"Wayengera, M. Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistry. PLoS ONE 4, e7420 (2009).","journal-title":"PLoS ONE"},{"key":"1138_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/pgmj.59.689.135","volume":"59","author":"EG Olsen","year":"1983","unstructured":"Olsen, E. G. Pathological aspects of endomyocardial fibrosis. Postgrad. Med. J. 59, 135\u2013141 (1983).","journal-title":"Postgrad. Med. J."},{"key":"1138_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.carpath.2007.12.009","volume":"18","author":"AO Mocumbi","year":"2009","unstructured":"Mocumbi, A. O. et al. Right ventricular endomyocardial fibrosis. Cardiovasc. Pathol. 18, 64\u201365 (2009).","journal-title":"Cardiovasc. Pathol."},{"key":"1138_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10554-010-9753-6","volume":"27","author":"AO Mocumbi","year":"2011","unstructured":"Mocumbi, A. O. et al. Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis. Int. J. Cardiovasc. Imaging 27, 955\u2013964 (2011).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"1138_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5339\/gcsp.2012.11","volume":"2012","author":"AO Mocumbi","year":"2012","unstructured":"Mocumbi, A. O. Endomyocardial fibrosis: a form of endemic restrictive cardiomyopathy. Glob. Cardiol. Sci. Pract. 2012, 11 (2012).","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"1138_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0035-9203(84)90169-X","volume":"78","author":"WM Eling","year":"1984","unstructured":"Eling, W. M., Jerusalem, C. R. & Heinen-Borries, U.\u00a0Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans. R. Soc. Trop. Med. Hyg. 78, 43\u201348 (1984).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"1138_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-008-0652-3","volume":"453","author":"SD Iglezias","year":"2008","unstructured":"Iglezias, S. D. et al. Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium. Virchows Arch. 453, 233\u2013241 (2008).","journal-title":"Virchows Arch."},{"key":"1138_CR33","first-page":"207","volume":"39","author":"JJ Andy","year":"2010","unstructured":"Andy, J. J., Ekott, J. U. & Ansa, V. O.\u00a0Systemic thromboembolism in endomyocardial fibrosis (EMF): clinical observations, aetio-pathogenesis and treatment. Afr. J. Med. Med. Sci. 39, 207\u2013213 (2010).","journal-title":"Afr. J. Med. Med. Sci."},{"key":"1138_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ejheart.2003.11.009","volume":"6","author":"S Seth","year":"2004","unstructured":"Seth, S., Thatai, D., Sharma, S., Chopra, P. & Talwar, K. K.\u00a0Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India. Eur. J. Heart Fail. 6, 723\u2013729 (2004).","journal-title":"Eur. J. Heart Fail."},{"key":"1138_CR35","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.cpcardiol.2023.101730","volume":"48","author":"ND Lungu","year":"2023","unstructured":"Lungu, N. D. & Dujawara, A. Complications of endomyocardial fibrosis and their physiological compromise: a review. Curr. Probl. Cardiol. 48, 101730 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"1138_CR36","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","volume":"133","author":"A Grimaldi","year":"2016","unstructured":"Grimaldi, A. et al. Tropical endomyocardial fibrosis: natural history, challenges, and perspectives. Circulation 133, 2503\u20132515 (2016).","journal-title":"Circulation"},{"key":"1138_CR37","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/S0140-6736(05)72932-9","volume":"355","author":"J Freers","year":"2000","unstructured":"Freers, J., Masembe, V., Schmauz, R. & Mayanja-Kizza, H. Endomyocardial fibrosis syndrome in Uganda. Lancet 355, 1994\u20131995 (2000).","journal-title":"Lancet"},{"key":"1138_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1086\/676746","volume":"4","author":"AO Mocumbi","year":"2014","unstructured":"Mocumbi, A. O. Right ventricular endomyocardial fibrosis (2013 Grover Conference series). Pulm. Circ. 4, 363\u2013369 (2014).","journal-title":"Pulm. Circ."},{"key":"1138_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jead282","volume":"25","author":"J\u00c1 S\u00e1nchez-Toscano","year":"2024","unstructured":"S\u00e1nchez-Toscano, J. A., Ruiz-Beltr\u00e1n, A. M., Arias-God\u00ednez, J. A., Rodr\u00edguez-Zanella, H. & Melendez-Ramirez, G.\u00a0Endomyocardial fibrosis secondary to eosinophilia due to parasitism. Eur. Heart J. Cardiovasc. Imaging 25, e109 (2024).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1138_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/0140-6736(93)92211-B","volume":"342","author":"J Freers","year":"1993","unstructured":"Freers, J., Amandua, J. & Mugerwa, R. Endomyocardial fibrosis and eosinophilia. Lancet 342, 1233 (1993).","journal-title":"Lancet"},{"key":"1138_CR41","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/hrt.2005.063610","volume":"91","author":"VM Salemi","year":"2005","unstructured":"Salemi, V. M., Rochitte, C E., Barbosa, M. M. & Mady, C. Images in cardiology. Clinical and echocardiographic dissociation in a patient with right ventricular endomyocardial fibrosis. Heart 91, 1399 (2005).","journal-title":"Heart"},{"key":"1138_CR42","first-page":"196","volume":"91","author":"JF V\u00e1squez-Rodr\u00edguez","year":"2021","unstructured":"V\u00e1squez-Rodr\u00edguez, J. F. et al. Endomyocardial fibrosis: a restrictive cardiomyopathy in developing countries. Arch. Cardiol. Mex. 91, 196\u2013201 (2021).","journal-title":"Arch. Cardiol. Mex."},{"key":"1138_CR43","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/echo.15153","volume":"38","author":"GT Gibson","year":"2021","unstructured":"Gibson, G. T. et al. Structural and functional cardiac changes in endomyocardial fibrosis treated with endomyocardial resection: disease progression captured by multimodality imaging. Echocardiography 38, 1641\u20131646 (2021).","journal-title":"Echocardiography"},{"key":"1138_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0894-7317(00)70008-3","volume":"13","author":"CS Berensztein","year":"2000","unstructured":"Berensztein, C. S. et al. Usefulness of echocardiography and Doppler echocardiography in endomyocardial fibrosis. J. Am. Soc. Echocardiogr. 13, 385\u2013392 (2000).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"1138_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0022-5223(19)39096-8","volume":"86","author":"D Metras","year":"1983","unstructured":"Metras, D., Ouezzin-Coulibaly, A., Ouattara, K., Bertrand, E. & Chauvet, J.\u00a0Endomyocardial fibrosis masquerading as rheumatic mitral incompetence. A report of six surgical cases. J. Thorac. Cardiovasc. Surg. 86, 753\u2013756 (1983).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1138_CR46","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.24976\/Discov.Med.202335179.101","volume":"35","author":"B Wu","year":"2023","unstructured":"Wu, B. et al. Application of routine echocardiography combined with contrast-enhanced echocardiography in the diagnosis of endomyocardial fibrosis. Discov. Med. 35, 1052\u20131063 (2023).","journal-title":"Discov. Med."},{"key":"1138_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21037\/cdt.2020.02.10","volume":"10","author":"CD Iroegbu","year":"2020","unstructured":"Iroegbu, C. D., Chen, W., Wu, X., Wu, M. & Yang, J.\u00a0Endomyocardial fibrosis. Cardiovasc. Diagn. Ther. 10, 208\u2013222 (2020).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"1138_CR48","doi-asserted-by":"publisher","first-page":"bcr2012006635","DOI":"10.1136\/bdr-2012-006635","volume":"2012","author":"AR Rajani","year":"2012","unstructured":"Rajani, A. R., Hussain, K., Baslaib, F. O. & Mirza, S. J. Endomyocardial fibrosis causing stroke in a young man. BMJ Case Rep. 2012, bcr2012006635 (2012).","journal-title":"BMJ Case Rep."},{"key":"1138_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.120.012093","volume":"14","author":"DDC Rassi","year":"2021","unstructured":"Rassi, D. D. C., Mar\u00e7al, P. C., Cruz, C. B. B. V., Masson Silva, J. B. & Hotta, V. T. Multimodality imaging in endomyocardial fibrosis: diagnosis and assessment of the extent of the disease. Circ. Cardiovasc. Imaging 14, e012093 (2021).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1138_CR50","first-page":"378","volume":"18","author":"VT Hotta","year":"2017","unstructured":"Hotta, V. T., Ianni, B. M., Assun\u00e7\u00e3o, A. N. Jr, Parga, J. R. & Mady, C.\u00a0Rare association of endomyocardial fibrosis and Chagas heart disease. Eur. Heart J. Cardiovasc. Imaging 18, 378\u2013379 (2017).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"1138_CR51","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.198.3.8628866","volume":"198","author":"E Mousseaux","year":"1996","unstructured":"Mousseaux, E. et al. Endomyocardial fibrosis: electron-beam CT features. Radiology 198, 755\u2013760 (1996).","journal-title":"Radiology"},{"key":"1138_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/eurheartj\/ehm372","volume":"29","author":"T Senra","year":"2007","unstructured":"Senra, T., Shiozaki, A. A., Salemi, V. M. & Rochitte, C. E.\u00a0Delayed enhancement by multidetector computed tomography in endomyocardial fibrosis. Eur. Heart J. 29, 347 (2007).","journal-title":"Eur. Heart J."},{"key":"1138_CR53","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.4330\/wjc.v6.i11.1192","volume":"6","author":"M Saeed","year":"2014","unstructured":"Saeed, M., Hetts, S. W., Jablonowski, R. & Wilson, M. W.\u00a0Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J. Cardiol. 6, 1192\u20131208 (2014).","journal-title":"World J. Cardiol."},{"key":"1138_CR54","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCIMAGING.110.950675","volume":"4","author":"VM Salemi","year":"2011","unstructured":"Salemi, V. M. et al. Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ. Cardiovasc. Imaging 4, 304\u2013311 (2011).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"1138_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.repc.2011.12.016","volume":"31","author":"D Leon","year":"2012","unstructured":"Leon, D. et al. Usefulness of cardiac MRI in the early diagnosis of endomyocardial fibrosis. Rev. Port. Cardiol. 31, 401\u2013402 (2012).","journal-title":"Rev. Port. Cardiol."},{"key":"1138_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-13-S1-O40","volume":"13","author":"AC Carneiro","year":"2011","unstructured":"Carneiro, A. C. A new typical finding in late gadolinium enhanced images for the diagnosis of endomyocardial fibrosis \u2013 the double V sign. J. Cardiovasc. Magn. Reson. 13, O40 (2011).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"1138_CR57","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1378\/chest.128.6.3985","volume":"128","author":"WM Hassan","year":"2005","unstructured":"Hassan, W. M., Fawzy, M. E., Al Helaly, S., Hegazy, H. & Malik, S. Pitfalls in diagnosis and clinical, echocardiographic, and hemodynamic findings in endomyocardial fibrosis: a 25-year experience. Chest 128, 3985\u20133992 (2005).","journal-title":"Chest"},{"key":"1138_CR58","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/echo.13244","volume":"33","author":"CP Maia","year":"2016","unstructured":"Maia, C. P. et al. A challenging differential diagnosis: distinguishing between endomyocardial fibrosis and apical hypertrophic cardiomyopathy. Echocardiography 33, 1080\u20131084 (2016).","journal-title":"Echocardiography"},{"key":"1138_CR59","doi-asserted-by":"publisher","first-page":"102462","DOI":"10.1016\/j.jflm.2022.102462","volume":"93","author":"C Rossetti","year":"2023","unstructured":"Rossetti, C. et al. A rare case of sudden death due to endomyocardial fibrosis in Italy: a differential diagnosis with other causes of restrictive cardiomyopathy. J. Forensic Leg. Med. 93, 102462 (2023).","journal-title":"J. Forensic Leg. Med."},{"key":"1138_CR60","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1148\/rg.2020190148","volume":"40","author":"F Penna de Carvalho","year":"2020","unstructured":"Penna de Carvalho, F. & Azevedo, C. F. Comprehensive assessment of endomyocardial fibrosis with cardiac MRI: morphology, function, and tissue characterisation. RadioGraphics 40, 336\u2013353 (2020).","journal-title":"RadioGraphics"},{"key":"1138_CR61","first-page":"214","volume":"17","author":"P Samuels","year":"2020","unstructured":"Samuels, P. et al. Cardiovascular magnetic resonance in endomyocardial fibrosis. SA Heart J. 17, 214\u2013216 (2020).","journal-title":"SA Heart J."},{"key":"1138_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/rheumatology\/ket328","volume":"53","author":"C Schneeweis","year":"2014","unstructured":"Schneeweis, C., Berger, A., Kelle, S., Fleck, E. & Gebker, R.\u00a0Endomyocardial fibrosis in patients with confirmed Churg\u2013Strauss syndrome. Rheumatology 53, 84 (2014).","journal-title":"Rheumatology"},{"key":"1138_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0167-5273(90)90067-F","volume":"28","author":"T Dave","year":"1990","unstructured":"Dave, T., Narula, J. P. & Chopra, P. \u00a0Myocardial and endocardial involvement in tuberculous constrictive pericarditis: difficulty in biopsy distinction from endomyocardial fibrosis as a cause of restrictive heart disease. Int. J. Cardiol. 28, 245\u2013251 (1990).","journal-title":"Int. J. Cardiol."},{"key":"1138_CR64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ha.2010.003525","volume":"3","author":"KM Subair","year":"2011","unstructured":"Subair, K. M. et al. The medical treatment of endomyocardial fibrosis in 2009. Heart Asia 3, 120\u2013123 (2011).","journal-title":"Heart Asia"},{"key":"1138_CR65","first-page":"349","volume":"62","author":"SA Adebonojo","year":"1977","unstructured":"Adebonojo, S. A. & Jaiyesimi, F. Pericardioperitoneal shunt for massive recurrent pericardial effusion in patients with endomyocardial fibrosis. Int. Surg. 62, 349\u2013350 (1977).","journal-title":"Int. Surg."},{"key":"1138_CR66","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1010-7940(99)00027-5","volume":"15","author":"F Moraes","year":"1999","unstructured":"Moraes, F. et al. Surgery for endomyocardial fibrosis revisited. Eur. J. Cardiothorac. Surg. 15, 309\u2013313 (1999).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"1138_CR67","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jocs.14378","volume":"35","author":"F Negri","year":"2020","unstructured":"Negri, F. et al. Endomyocardial fibrosis of the right ventricle: a case report of successful surgery. J. Card. Surg. 35, 460\u2013463 (2020).","journal-title":"J. Card. Surg."},{"key":"1138_CR68","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/hrt.79.4.362","volume":"79","author":"U Schneider","year":"1998","unstructured":"Schneider, U., Jenni, R., Turina, J., Turina, M. & Hess, O. M. Long-term follow up of patients with endomyocardial fibrosis: effects of surgery. Heart 79, 362\u2013367 (1998).","journal-title":"Heart"},{"key":"1138_CR69","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jocs.12159","volume":"28","author":"A Fiore","year":"2013","unstructured":"Fiore, A., Grande, A. M., Pellegrini, C., Vigan\u00f2, M. & Massetti, M.\u00a0Long-term survival following surgery for endomyocardial fibrosis. J. Card. Surg. 28, 675\u2013677 (2013).","journal-title":"J. Card. Surg."},{"key":"1138_CR70","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jtcvs.2007.04.062","volume":"134","author":"AO Mocumbi","year":"2007","unstructured":"Mocumbi, A.O., Sidi, D., Vouhe, P. & Yacoub, M.\u00a0An innovative technique for the relief of right ventricular trabecular cavity obliteration in endomyocardial fibrosis. J. Thorac. Cardiovasc. Surg. 134, 1070\u20131072 (2007).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1138_CR71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/cdt.2019.08.07","volume":"10","author":"J Mbanze","year":"2020","unstructured":"Mbanze, J., Cumbane, B., Jive, R. & Mocumbi, A. Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies. Cardiovasc. Diagn. Ther. 10, 279\u2013288 (2020).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"1138_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0022-5223(19)37324-6","volume":"83","author":"D Metras","year":"1982","unstructured":"Metras, D. et al. Endomyocardial fibrosis: early and late results of surgery in 20 patients. J. Thorac. Cardiovasc. Surg. 83, 52\u201364 (1982).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1138_CR73","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/thx.38.6.421","volume":"38","author":"MS Valiathan","year":"1983","unstructured":"Valiathan, M. S. et al. Surgical palliation for endomyocardial fibrosis: early results. Thorax 38, 421\u2013427 (1983).","journal-title":"Thorax"},{"key":"1138_CR74","first-page":"417","volume":"51","author":"E Bertrand","year":"1974","unstructured":"Bertrand, E. et al. Etude de 14 cas de fibrose endomyocardique (ou fibrose endocardique constrictive). Importance des documents h\u00e9modynamiques et m\u00e9canographiques [A study of 14 cases of endomyocardial fibrosis (or constrictive endocardial fibrosis). The importance of hemodynamic and mechanographic data]. Bull. World Health Organ. 51, 417\u2013422 (1974).","journal-title":"Bull. World Health Organ."},{"key":"1138_CR75","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0003-4975(10)61409-9","volume":"34","author":"AE Wood","year":"1982","unstructured":"Wood, A. E. et al. Mitral annuloplasty in endomyocardial fibrosis: an alternative to valve replacement. Ann. Thorac. Surg. 34, 446\u2013451 (1982).","journal-title":"Ann. Thorac. Surg."},{"key":"1138_CR76","first-page":"35","volume":"33","author":"E Bertrand","year":"1984","unstructured":"Bertrand, E. La fibrose endomyocardique ou endocardite fibroplastique. Indications et r\u00e9sultats du traitement chirurgical [Endomyocardial fibrosis or fibroplastic endocarditis. Indications and results of surgical treatment]. Ann. Cardiol. Angeiol. 33, 35\u201341 (1984).","journal-title":"Ann. Cardiol. Angeiol."},{"key":"1138_CR77","first-page":"ii274","volume":"72","author":"D Metras","year":"1985","unstructured":"Metras, D. et al. The surgical treatment of endomyocardial fibrosis: results in 55 patients. Circulation 72, ii274\u2013ii279 (1985).","journal-title":"Circulation"},{"key":"1138_CR78","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/jcu.23003","volume":"49","author":"B Uygur","year":"2021","unstructured":"Uygur, B. et al. Detection of a rare cause of pulmonary hypertension by multimodality imaging: left ventricular endomyocardial fibrosis. J. Clin. Ultrasound 49, 520\u2013524 (2021).","journal-title":"J. Clin. Ultrasound"},{"key":"1138_CR79","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.athoracsur.2011.06.011","volume":"93","author":"A Heredero","year":"2012","unstructured":"Heredero, A. et al. Combined endocardiectomy and bidirectional Glenn shunt for right ventricular endomyocardial fibrosis. Ann. Thorac. Surg. 93, 310\u2013312 (2012).","journal-title":"Ann. Thorac. Surg."},{"key":"1138_CR80","first-page":"400","volume":"10","author":"VM Salemi","year":"2009","unstructured":"Salemi, V. M. et al. Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients. Eur. J. Echocardiogr. 10, 400\u2013405 (2009).","journal-title":"Eur. J. Echocardiogr."},{"key":"1138_CR81","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/HCR.0000000000000445","volume":"39","author":"ALC Sayegh","year":"2019","unstructured":"Sayegh, A. L. C. et al. Exercise rehabilitation improves cardiac volumes and functional capacity in patients with endomyocardial fibrosis: a randomized controlled trial. J. Cardiopulm. Rehabil. Prev. 39, 373\u2013380 (2019).","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"1138_CR82","first-page":"533","volume":"109","author":"ALC Sayegh","year":"2017","unstructured":"Sayegh, A. L. C. et al. Characterization of cardiopulmonary exercise testing variables in patients with endomyocardial fibrosis after endocardial resection. Arq. Bras. Cardiol. 109, 533\u2013540 (2017).","journal-title":"Arq. Bras. Cardiol."},{"key":"1138_CR83","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2021.02.026","volume":"333","author":"SM Kraus","year":"2021","unstructured":"Kraus, S. M. et al. Rationale and design of the African cardiomyopathy and myocarditis registry program: the IMHOTEP study. Int. J. Cardiol. 333, 119\u2013126 (2021).","journal-title":"Int. J. Cardiol."},{"key":"1138_CR84","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11897-022-00569-8","volume":"19","author":"A Suresh","year":"2022","unstructured":"Suresh, A. et al. Biomarkers for myocarditis and inflammatory cardiomyopathy. Curr. Heart Fail. Rep. 19, 346\u2013355 (2022).","journal-title":"Curr. Heart Fail. Rep."},{"key":"1138_CR85","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrcardio.2010.51","volume":"7","author":"G De Couto","year":"2010","unstructured":"De Couto, G. et al. Early detection of myocardial dysfunction and heart failure. Nat. Rev. Cardiol. 7, 334\u2013344 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"1138_CR86","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/biom10030389","volume":"10","author":"A Hara","year":"2020","unstructured":"Hara, A. et al. Galectin-3 as a next-generation biomarker for detecting early stage of various diseases. Biomolecules 10, 389 (2020).","journal-title":"Biomolecules"},{"key":"1138_CR87","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12872-022-02647-0","volume":"22","author":"G Bolla","year":"2022","unstructured":"Bolla, G. et al. Effects of Sacubitril\/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction. BMC Cardiovasc. Disord. 22, 217 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1138_CR88","unstructured":"US National Library of Medicine. ClinicalTrials.gov www.clinicaltrials.gov\/study\/NCT01842854 (2017)."},{"key":"1138_CR89","unstructured":"US National Library of Medicine. ClinicalTrials.gov www.clinicaltrials.gov\/study\/NCT01960946 (2021)."},{"key":"1138_CR90","unstructured":"US National Library of Medicine. ClinicalTrials.gov www.clinicaltrials.gov\/study\/NCT03413072 (2018)."},{"key":"1138_CR91","unstructured":"US National Library of Medicine. ClinicalTrials.gov www.clinicaltrials.gov\/study\/NCT01210157 (2010)."},{"key":"1138_CR92","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.mehy.2006.05.034","volume":"67","author":"M Pan","year":"2006","unstructured":"Pan, M. et al. Inflammation: a possible pathogenic link to atrial fibrillation. Med. Hypotheses 67, 1305\u20131307 (2006).","journal-title":"Med. Hypotheses"},{"key":"1138_CR93","first-page":"155","volume":"12","author":"JJ Andy","year":"1983","unstructured":"Andy, J. J. Helminthiasis, the hypereosinophilic syndrome and endomyocardial fibrosis: some observations and an hypothesis. Afr. J. Med. Med Sci. 12, 155\u2013164 (1983).","journal-title":"Afr. J. Med. Med Sci."},{"key":"1138_CR94","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1007\/s00134-018-5300-z","volume":"44","author":"D Doyen","year":"2018","unstructured":"Doyen, D. et al. Endomyocardial fibrosis complicating primary hypereosinophilic syndrome. Intensive Care Med. 44, 2294\u20132295 (2018).","journal-title":"Intensive Care Med."},{"key":"1138_CR95","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4049\/jimmunol.157.3.1219","volume":"157","author":"V Patella","year":"1996","unstructured":"Patella, V. et al. Eosinophil granule proteins activate human heart mast cells. J. Immunol. 157, 1219\u20131225 (1996).","journal-title":"J. Immunol."},{"key":"1138_CR96","first-page":"1","volume":"5","author":"CS Yadavalli","year":"2022","unstructured":"Yadavalli, C. S. & Mishra, A. IL-5 overexpression induced blood eosinophilia associated progression of cardiac abnormalities. Int. J. Basic. Clin. Immunol. 5, 1\u20137 (2022).","journal-title":"Int. J. Basic. Clin. Immunol."},{"key":"1138_CR97","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1182\/blood.V88.12.4684.bloodjournal88124684","volume":"88","author":"J Elsner","year":"1996","unstructured":"Elsner, J., H\u00f6chstetter, R., Spiekermann, K. & Kapp, A.\u00a0Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. Blood 88, 4684\u20134693 (1996).","journal-title":"Blood"},{"key":"1138_CR98","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1586\/1744666X.1.4.633","volume":"1","author":"ML Stein","year":"2005","unstructured":"Stein, M. L. & Rothenberg, M. E. Hypereosinophilic syndromes and new therapeutic approaches including anti-IL5. Expert. Rev. Clin. Immunol. 1, 633\u2013644 (2005).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"1138_CR99","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3324\/haematol.11420","volume":"92","author":"M Baccarani","year":"2007","unstructured":"Baccarani, M. et al. The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR\u03b1-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Haematologica 92, 1173\u20131179 (2007).","journal-title":"Haematologica"},{"key":"1138_CR100","first-page":"35","volume":"9","author":"AS Dal Berto","year":"2018","unstructured":"Dal Berto, A. S., Cami\u00f1a, R. H., Machado, E.S. & Baptistella, A. R.\u00a0FIP1L1-PDGFRA fusion-negative hypereosinophilic syndrome with uncommon cardiac involvement responding to imatinib treatment: a case report. Mol. Clin. Oncol. 9, 35\u201339 (2018).","journal-title":"Mol. Clin. Oncol."},{"key":"1138_CR101","doi-asserted-by":"publisher","first-page":"114690","DOI":"10.1016\/j.bcp.2021.114690","volume":"192","author":"P Luschnig","year":"2021","unstructured":"Luschnig, P. et al. The JAK1\/2 inhibitor baricitinib suppresses eosinophil effector function and restricts allergen-induced airway eosinophilia. Biochem. Pharmacol. 192, 114690 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"1138_CR102","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.3390\/ijms23084195","volume":"23","author":"J Kruszewska","year":"2022","unstructured":"Kruszewska, J., Cudnoch-Jedrzejewska, A. & Czarzasta, K.\u00a0Remodeling and fibrosis of the cardiac muscle in the course of obesity-pathogenesis and involvement of the extracellular matrix. Int. J. Mol. Sci. 23, 4195 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1138_CR103","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","volume":"12","author":"R Burke","year":"2019","unstructured":"Burke, R. M., Lighthouse, J. K., Mickelsen, D. M. & Small, E. M.\u00a0Sacubitril\/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts. Circ. Heart Fail. 12, e005565 (2019).","journal-title":"Circ. Heart Fail."},{"key":"1138_CR104","doi-asserted-by":"publisher","first-page":"760035","DOI":"10.3389\/fcell.2021.760035","volume":"9","author":"T Jia","year":"2021","unstructured":"Jia, T. et al. Sacubitril ameliorates cardiac fibrosis through inhibiting TRPM7 channel. Front. Cell Dev. Biol. 9, 760035 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1138_CR105","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fphys.2019.00159","volume":"10","author":"D Falc\u00f3n","year":"2019","unstructured":"Falc\u00f3n, D. et al. TRP channels: current perspectives in the adverse cardiac remodeling. Front. Physiol. 10, 159 (2019).","journal-title":"Front. Physiol."},{"key":"1138_CR106","doi-asserted-by":"publisher","first-page":"110072","DOI":"10.1016\/j.intimp.2023.110072","volume":"118","author":"Y Chen","year":"2023","unstructured":"Chen, Y. & Peng, D. New insights into the molecular mechanisms of SGLT2 inhibitors on ventricular remodeling. Int. Immunopharmacol. 118, 110072 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"1138_CR107","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/bph.16236","volume":"180","author":"MJ De Blasio","year":"2023","unstructured":"De Blasio, M. J., Ohlstein, E. H. & Ritchie, R. H.\u00a0Therapeutic targets of fibrosis: translational advances and current challenges. Br. J. Pharmacol. 180, 2839\u20132845 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"1138_CR108","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1111\/bph.15967","volume":"180","author":"B Ohm","year":"2023","unstructured":"Ohm, B., Moneke, I. & Jungraithmayr, W.\u00a0Targeting cluster of differentiation 26\/dipeptidylpeptidase 4 (CD26\/DPP4) in organ fibrosis. Br. J. Pharmacol. 180, 2846\u20132861 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"1138_CR109","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11302-023-09952-z","volume":"20","author":"M Bessa-Gon\u00e7alves","year":"2024","unstructured":"Bessa-Gon\u00e7alves, M. et al. Blockage of the adenosine A2B receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension. Purinergic Signal 20, 163\u2013179 (2024).","journal-title":"Purinergic Signal"},{"key":"1138_CR110","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/cells9030651","volume":"9","author":"C Herman-de-Sousa","year":"2020","unstructured":"Herman-de-Sousa, C. et al. Opposing effects of adenosine and inosine in human subcutaneous fibroblasts may be regulated by third party ADA cell providers. Cells 9, 651 (2020).","journal-title":"Cells"},{"key":"1138_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229158","volume":"15","author":"P Orozco","year":"2020","unstructured":"Orozco, P., Montoya, Y. & Bustamante, J. Development of endomyocardial fibrosis model using a cell patterning technique: in vitro interaction of cell coculture of 3T3 fibroblasts and RL-14 cardiomyocytes. PLoS ONE 15, e0229158 (2020).","journal-title":"PLoS ONE"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01138-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01138-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01138-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:24:13Z","timestamp":1757143453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-025-01138-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1138"],"URL":"https:\/\/doi.org\/10.1038\/s41569-025-01138-x","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"type":"print","value":"1759-5002"},{"type":"electronic","value":"1759-5010"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"5 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}